Share Price and Basic Stock Data
Last Updated: January 29, 2026, 6:40 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Norben Tea & Exports Ltd operates in the Plantations sector, specifically focusing on tea and coffee production. The company’s market capitalization stood at ₹133 Cr, with its share price at ₹85.9. Revenue trends indicate a fluctuating sales performance, with total sales reported at ₹7.78 Cr for FY 2023, a rise from ₹5.97 Cr in FY 2022. The latest quarterly sales for September 2023 recorded ₹2.24 Cr, showing a recovery from lower sales in previous quarters, such as ₹0.74 Cr in March 2023. However, the company has faced challenges, with a total revenue of ₹6.58 Cr projected for FY 2024, reflecting a decline compared to FY 2023. This inconsistency in revenue generation underscores the volatility in the tea and coffee market, influenced by fluctuating demand and possibly adverse weather conditions impacting production. The company’s sales trajectory, while showing short-term improvements, requires sustained growth to stabilize its market position.
Profitability and Efficiency Metrics
Norben Tea reported a net profit of -₹0.78 Cr for the latest fiscal year, which reflects ongoing profitability challenges. The operating profit margin (OPM) stood at 21.34%, demonstrating a capacity for profit generation when sales are consistent. However, the company has seen varying profitability; for instance, the OPM peaked at 48.21% in September 2023 but dropped to -69.29% in December 2023. The return on equity (ROE) was recorded at a mere 1.22%, indicating insufficient shareholder returns relative to equity. The interest coverage ratio (ICR) of 1.38x suggests that the company can cover its interest obligations, albeit with limited buffer. Efficiency metrics such as the cash conversion cycle (CCC) stood at 6.68 days, indicating effective management of cash flows. While the company demonstrates potential in profitability during select quarters, the overall trend remains concerning, necessitating strategic improvements.
Balance Sheet Strength and Financial Ratios
The balance sheet of Norben Tea reflects a total borrowing of ₹8.59 Cr against reserves of ₹4.46 Cr, highlighting a reliance on debt financing. The debt-to-equity ratio stood at 0.61, which is relatively moderate, indicating that the company is not excessively leveraged compared to industry standards. The current ratio was reported at 0.51, suggesting potential liquidity challenges as it falls below the typical benchmark of 1. This could impact the company’s ability to meet short-term obligations effectively. Additionally, the price-to-book value (P/BV) ratio of 3.11x indicates that the stock is trading at a premium, which may not be justified given the recent profitability issues. The book value per share has slightly increased to ₹11.74, but the company needs to enhance its asset utilization to improve the return on capital employed (ROCE), which stood at 3.90%. Overall, while the balance sheet shows some strengths, the liquidity and profitability ratios raise concerns about financial stability.
Shareholding Pattern and Investor Confidence
Norben Tea’s shareholding pattern displays a significant shift in promoter holdings, which decreased from 51.45% in March 2023 to 38.89% in September 2025. This decline may signal reduced confidence among promoters, potentially impacting investor sentiment. Conversely, public shareholding has increased substantially from 48.42% in December 2022 to 61.01% in September 2025, indicating growing interest from retail investors. Institutional investment remains minimal, with foreign institutional investors (FIIs) being absent and domestic institutional investors (DIIs) holding only 0.09% of shares. This limited institutional backing may reflect caution among larger investors regarding the company’s financial performance and market stability. With over 25,000 shareholders, the company has a broad base of retail investors, but the declining promoter stake could raise concerns about future governance and strategic direction.
Outlook, Risks, and Final Insight
The outlook for Norben Tea & Exports Ltd remains mixed, with the potential for recovery dependent on strategic management decisions and market conditions. Strengths include its capacity to achieve high operating profit margins in certain quarters and a manageable level of debt. However, risks such as fluctuating sales, declining profitability, and a weakening promoter stake raise concerns about long-term sustainability. The company must enhance operational efficiency and explore new markets to stabilize revenue. Moreover, improving liquidity metrics and attracting institutional investors could bolster investor confidence. Should the company effectively address these challenges, it might pave the way for a more robust financial future; otherwise, continued volatility could hinder growth prospects. The focus on innovation in product offerings and market expansion will be crucial to overcoming the current hurdles.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 330 Cr. | 153 | 275/150 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 | |
| Diana Tea Company Ltd | 39.9 Cr. | 26.6 | 42.0/23.3 | 47.3 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 142 Cr. | 158 | 185/126 | 27.7 | 223 | 0.95 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 10.0 Cr. | 15.9 | 15.9/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 118 Cr. | 380 | 685/350 | 12.6 | 528 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 8,461.06 Cr | 375.57 | 64.25 | 265.00 | 0.45% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.81 | 2.06 | 0.74 | 1.75 | 2.24 | 1.40 | 1.18 | 1.29 | 3.27 | 2.02 | 1.08 | 1.23 | 2.39 |
| Expenses | 2.07 | 1.79 | 0.67 | 1.33 | 1.16 | 2.37 | 1.79 | 0.84 | 1.90 | 1.78 | 1.61 | 0.57 | 1.88 |
| Operating Profit | 0.74 | 0.27 | 0.07 | 0.42 | 1.08 | -0.97 | -0.61 | 0.45 | 1.37 | 0.24 | -0.53 | 0.66 | 0.51 |
| OPM % | 26.33% | 13.11% | 9.46% | 24.00% | 48.21% | -69.29% | -51.69% | 34.88% | 41.90% | 11.88% | -49.07% | 53.66% | 21.34% |
| Other Income | 0.00 | 0.00 | 0.03 | 0.01 | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Interest | 0.10 | 0.36 | 0.29 | 0.18 | 0.25 | 0.37 | 0.27 | 0.28 | 0.27 | 0.25 | 0.34 | 0.23 | 0.25 |
| Depreciation | 0.14 | 0.12 | 0.16 | 0.14 | 0.14 | 0.15 | 0.15 | 0.15 | 0.14 | 0.15 | 0.17 | 0.15 | 0.15 |
| Profit before tax | 0.50 | -0.21 | -0.35 | 0.11 | 0.69 | -1.47 | -1.02 | 0.03 | 0.97 | -0.15 | -1.03 | 0.29 | 0.11 |
| Tax % | 0.00% | 0.00% | 34.29% | 0.00% | 0.00% | 0.00% | 1.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 0.51 | -0.21 | -0.48 | 0.12 | 0.69 | -1.47 | -1.03 | 0.04 | 0.97 | -0.15 | -1.03 | 0.29 | 0.11 |
| EPS in Rs | 0.43 | -0.18 | -0.41 | 0.10 | 0.59 | -1.25 | -0.88 | 0.03 | 0.83 | -0.13 | -0.79 | 0.22 | 0.07 |
Last Updated: January 11, 2026, 6:17 am
Below is a detailed analysis of the quarterly data for Norben Tea & Exports Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 2.39 Cr.. The value appears strong and on an upward trend. It has increased from 1.23 Cr. (Jun 2025) to 2.39 Cr., marking an increase of 1.16 Cr..
- For Expenses, as of Sep 2025, the value is 1.88 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.57 Cr. (Jun 2025) to 1.88 Cr., marking an increase of 1.31 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.51 Cr.. The value appears to be declining and may need further review. It has decreased from 0.66 Cr. (Jun 2025) to 0.51 Cr., marking a decrease of 0.15 Cr..
- For OPM %, as of Sep 2025, the value is 21.34%. The value appears to be declining and may need further review. It has decreased from 53.66% (Jun 2025) to 21.34%, marking a decrease of 32.32%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 0.01 Cr..
- For Interest, as of Sep 2025, the value is 0.25 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.23 Cr. (Jun 2025) to 0.25 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.15 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.15 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.11 Cr.. The value appears to be declining and may need further review. It has decreased from 0.29 Cr. (Jun 2025) to 0.11 Cr., marking a decrease of 0.18 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 0.11 Cr.. The value appears to be declining and may need further review. It has decreased from 0.29 Cr. (Jun 2025) to 0.11 Cr., marking a decrease of 0.18 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.07. The value appears to be declining and may need further review. It has decreased from 0.22 (Jun 2025) to 0.07, marking a decrease of 0.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:53 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.93 | 3.73 | 4.72 | 4.70 | 4.64 | 5.40 | 4.87 | 7.46 | 5.97 | 7.78 | 6.58 | 7.65 | 6.72 |
| Expenses | 3.46 | 3.48 | 4.22 | 4.12 | 4.59 | 4.72 | 5.26 | 5.05 | 5.06 | 6.09 | 6.64 | 6.12 | 5.84 |
| Operating Profit | 0.47 | 0.25 | 0.50 | 0.58 | 0.05 | 0.68 | -0.39 | 2.41 | 0.91 | 1.69 | -0.06 | 1.53 | 0.88 |
| OPM % | 11.96% | 6.70% | 10.59% | 12.34% | 1.08% | 12.59% | -8.01% | 32.31% | 15.24% | 21.72% | -0.91% | 20.00% | 13.10% |
| Other Income | 0.38 | 0.62 | 0.17 | 0.41 | 0.76 | -0.05 | 0.07 | 0.06 | 0.07 | 0.03 | 0.03 | 0.03 | 0.03 |
| Interest | 0.30 | 0.33 | 0.36 | 0.47 | 0.51 | 0.58 | 0.72 | 0.68 | 0.66 | 0.83 | 1.07 | 1.13 | 1.07 |
| Depreciation | 0.32 | 0.23 | 0.25 | 0.36 | 0.38 | 0.43 | 0.47 | 0.50 | 0.52 | 0.55 | 0.58 | 0.60 | 0.62 |
| Profit before tax | 0.23 | 0.31 | 0.06 | 0.16 | -0.08 | -0.38 | -1.51 | 1.29 | -0.20 | 0.34 | -1.68 | -0.17 | -0.78 |
| Tax % | 43.48% | 25.81% | 33.33% | 100.00% | -25.00% | 18.42% | 6.62% | 9.30% | 30.00% | 35.29% | 1.19% | 0.00% | |
| Net Profit | 0.13 | 0.23 | 0.03 | 0.01 | -0.05 | -0.45 | -1.61 | 1.18 | -0.27 | 0.21 | -1.70 | -0.18 | -0.78 |
| EPS in Rs | 0.11 | 0.20 | 0.03 | 0.01 | -0.04 | -0.38 | -1.37 | 1.00 | -0.23 | 0.18 | -1.45 | -0.14 | -0.63 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 76.92% | -86.96% | -66.67% | -600.00% | -800.00% | -257.78% | 173.29% | -122.88% | 177.78% | -909.52% | 89.41% |
| Change in YoY Net Profit Growth (%) | 0.00% | -163.88% | 20.29% | -533.33% | -200.00% | 542.22% | 431.07% | -296.17% | 300.66% | -1087.30% | 998.94% |
Norben Tea & Exports Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 10% |
| TTM: | 105% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 81% |
| 1 Year: | 167% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -1% |
| 3 Years: | -4% |
| Last Year: | -1% |
Last Updated: September 5, 2025, 11:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:44 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.75 | 11.75 | 11.75 | 11.75 | 11.75 | 11.75 | 11.75 | 11.75 | 11.75 | 11.75 | 11.75 | 12.97 | 15.54 |
| Reserves | 3.65 | 3.88 | 3.91 | 4.08 | 4.01 | 3.55 | 1.93 | 3.10 | 2.86 | 3.10 | 1.35 | 3.35 | 4.46 |
| Borrowings | 2.23 | 2.74 | 3.34 | 4.54 | 5.49 | 6.43 | 7.58 | 6.58 | 7.70 | 9.05 | 10.43 | 9.34 | 8.59 |
| Other Liabilities | 0.54 | 0.64 | 0.82 | 0.73 | 0.83 | 0.91 | 1.40 | 1.53 | 1.79 | 1.82 | 2.29 | 2.41 | 3.04 |
| Total Liabilities | 18.17 | 19.01 | 19.82 | 21.10 | 22.08 | 22.64 | 22.66 | 22.96 | 24.10 | 25.72 | 25.82 | 28.07 | 31.63 |
| Fixed Assets | 14.97 | 15.62 | 16.17 | 16.70 | 18.43 | 19.13 | 19.47 | 20.19 | 20.73 | 21.86 | 22.49 | 23.63 | 24.40 |
| CWIP | 0.00 | 0.00 | 0.17 | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Other Assets | 3.20 | 3.39 | 3.48 | 3.78 | 3.65 | 3.51 | 3.19 | 2.77 | 3.18 | 3.85 | 3.33 | 4.44 | 7.23 |
| Total Assets | 18.17 | 19.01 | 19.82 | 21.10 | 22.08 | 22.64 | 22.66 | 22.96 | 24.10 | 25.72 | 25.82 | 28.07 | 31.63 |
Below is a detailed analysis of the balance sheet data for Norben Tea & Exports Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.54 Cr.. The value appears strong and on an upward trend. It has increased from 12.97 Cr. (Mar 2025) to 15.54 Cr., marking an increase of 2.57 Cr..
- For Reserves, as of Sep 2025, the value is 4.46 Cr.. The value appears strong and on an upward trend. It has increased from 3.35 Cr. (Mar 2025) to 4.46 Cr., marking an increase of 1.11 Cr..
- For Borrowings, as of Sep 2025, the value is 8.59 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 9.34 Cr. (Mar 2025) to 8.59 Cr., marking a decrease of 0.75 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.41 Cr. (Mar 2025) to 3.04 Cr., marking an increase of 0.63 Cr..
- For Total Liabilities, as of Sep 2025, the value is 31.63 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.07 Cr. (Mar 2025) to 31.63 Cr., marking an increase of 3.56 Cr..
- For Fixed Assets, as of Sep 2025, the value is 24.40 Cr.. The value appears strong and on an upward trend. It has increased from 23.63 Cr. (Mar 2025) to 24.40 Cr., marking an increase of 0.77 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 7.23 Cr.. The value appears strong and on an upward trend. It has increased from 4.44 Cr. (Mar 2025) to 7.23 Cr., marking an increase of 2.79 Cr..
- For Total Assets, as of Sep 2025, the value is 31.63 Cr.. The value appears strong and on an upward trend. It has increased from 28.07 Cr. (Mar 2025) to 31.63 Cr., marking an increase of 3.56 Cr..
However, the Borrowings (8.59 Cr.) are higher than the Reserves (4.46 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.76 | -2.49 | -2.84 | -3.96 | -5.44 | -5.75 | -7.97 | -4.17 | -6.79 | -7.36 | -10.49 | -7.81 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13.93 | 19.57 | 17.01 | 17.86 | 12.59 | 24.33 | 17.24 | 13.70 | 17.12 | 12.67 | 6.66 | 6.68 |
| Inventory Days | 808.92 | |||||||||||
| Days Payable | 394.59 | |||||||||||
| Cash Conversion Cycle | 13.93 | 19.57 | 17.01 | 17.86 | 12.59 | 24.33 | 17.24 | 13.70 | 17.12 | 12.67 | 420.98 | 6.68 |
| Working Capital Days | -20.43 | -23.49 | -34.03 | -49.70 | -308.36 | -347.43 | -155.89 | -109.11 | -146.73 | -118.70 | -221.88 | -155.07 |
| ROCE % | 4.17% | 3.50% | 2.25% | 3.20% | 2.07% | 1.58% | -3.68% | 9.23% | 2.10% | 5.02% | -2.57% | 3.90% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.15 | -1.45 | 0.18 | -0.23 | 1.00 |
| Diluted EPS (Rs.) | -0.14 | -1.45 | 0.18 | -0.23 | 1.00 |
| Cash EPS (Rs.) | 0.32 | -0.95 | 0.64 | 0.21 | 1.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 11.74 | 11.15 | 12.64 | 12.43 | 12.64 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 11.74 | 11.15 | 12.64 | 12.43 | 12.64 |
| Revenue From Operations / Share (Rs.) | 5.90 | 5.59 | 6.62 | 5.08 | 6.35 |
| PBDIT / Share (Rs.) | 1.20 | -0.02 | 1.46 | 0.83 | 2.10 |
| PBIT / Share (Rs.) | 0.73 | -0.51 | 0.99 | 0.38 | 1.68 |
| PBT / Share (Rs.) | -0.13 | -1.43 | 0.28 | -0.17 | 1.10 |
| Net Profit / Share (Rs.) | -0.13 | -1.45 | 0.18 | -0.22 | 1.00 |
| PBDIT Margin (%) | 20.40 | -0.45 | 22.01 | 16.42 | 33.13 |
| PBIT Margin (%) | 12.52 | -9.28 | 14.96 | 7.67 | 26.49 |
| PBT Margin (%) | -2.26 | -25.60 | 4.34 | -3.39 | 17.31 |
| Net Profit Margin (%) | -2.30 | -25.86 | 2.72 | -4.46 | 15.77 |
| Return on Networth / Equity (%) | -1.16 | -12.98 | 1.42 | -1.82 | 7.92 |
| Return on Capital Employeed (%) | 4.27 | -2.98 | 5.49 | 2.27 | 10.05 |
| Return On Assets (%) | -0.62 | -6.58 | 0.82 | -1.10 | 5.12 |
| Long Term Debt / Equity (X) | 0.37 | 0.50 | 0.39 | 0.33 | 0.29 |
| Total Debt / Equity (X) | 0.61 | 0.79 | 0.60 | 0.52 | 0.44 |
| Asset Turnover Ratio (%) | 0.28 | 0.25 | 0.31 | 0.25 | 0.32 |
| Current Ratio (X) | 0.51 | 0.31 | 0.49 | 0.42 | 0.40 |
| Quick Ratio (X) | 0.27 | 0.15 | 0.21 | 0.16 | 0.24 |
| Inventory Turnover Ratio (X) | 6.88 | 6.13 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 1.38 | -0.02 | 2.07 | 1.48 | 3.61 |
| Interest Coverage Ratio (Post Tax) (X) | 0.84 | -0.58 | 1.26 | 0.59 | 2.72 |
| Enterprise Value (Cr.) | 56.21 | 25.30 | 17.87 | 10.17 | 9.03 |
| EV / Net Operating Revenue (X) | 7.35 | 3.85 | 2.30 | 1.71 | 1.21 |
| EV / EBITDA (X) | 36.00 | -847.15 | 10.44 | 10.38 | 3.65 |
| MarketCap / Net Operating Revenue (X) | 6.19 | 2.31 | 1.17 | 0.43 | 0.34 |
| Price / BV (X) | 3.11 | 1.16 | 0.61 | 0.17 | 0.17 |
| Price / Net Operating Revenue (X) | 6.19 | 2.31 | 1.17 | 0.43 | 0.34 |
| EarningsYield | 0.00 | -0.11 | 0.02 | -0.10 | 0.45 |
After reviewing the key financial ratios for Norben Tea & Exports Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.15. This value is below the healthy minimum of 5. It has increased from -1.45 (Mar 24) to -0.15, marking an increase of 1.30.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.14. This value is below the healthy minimum of 5. It has increased from -1.45 (Mar 24) to -0.14, marking an increase of 1.31.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 3. It has increased from -0.95 (Mar 24) to 0.32, marking an increase of 1.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 11.74. It has increased from 11.15 (Mar 24) to 11.74, marking an increase of 0.59.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 11.74. It has increased from 11.15 (Mar 24) to 11.74, marking an increase of 0.59.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 5.90. It has increased from 5.59 (Mar 24) to 5.90, marking an increase of 0.31.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.20. This value is below the healthy minimum of 2. It has increased from -0.02 (Mar 24) to 1.20, marking an increase of 1.22.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.73. This value is within the healthy range. It has increased from -0.51 (Mar 24) to 0.73, marking an increase of 1.24.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.13. This value is below the healthy minimum of 0. It has increased from -1.43 (Mar 24) to -0.13, marking an increase of 1.30.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.13. This value is below the healthy minimum of 2. It has increased from -1.45 (Mar 24) to -0.13, marking an increase of 1.32.
- For PBDIT Margin (%), as of Mar 25, the value is 20.40. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 20.40, marking an increase of 20.85.
- For PBIT Margin (%), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -9.28 (Mar 24) to 12.52, marking an increase of 21.80.
- For PBT Margin (%), as of Mar 25, the value is -2.26. This value is below the healthy minimum of 10. It has increased from -25.60 (Mar 24) to -2.26, marking an increase of 23.34.
- For Net Profit Margin (%), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 5. It has increased from -25.86 (Mar 24) to -2.30, marking an increase of 23.56.
- For Return on Networth / Equity (%), as of Mar 25, the value is -1.16. This value is below the healthy minimum of 15. It has increased from -12.98 (Mar 24) to -1.16, marking an increase of 11.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.27. This value is below the healthy minimum of 10. It has increased from -2.98 (Mar 24) to 4.27, marking an increase of 7.25.
- For Return On Assets (%), as of Mar 25, the value is -0.62. This value is below the healthy minimum of 5. It has increased from -6.58 (Mar 24) to -0.62, marking an increase of 5.96.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has decreased from 0.50 (Mar 24) to 0.37, marking a decrease of 0.13.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.61. This value is within the healthy range. It has decreased from 0.79 (Mar 24) to 0.61, marking a decrease of 0.18.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.28. It has increased from 0.25 (Mar 24) to 0.28, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1.5. It has increased from 0.31 (Mar 24) to 0.51, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.15 (Mar 24) to 0.27, marking an increase of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.88. This value is within the healthy range. It has increased from 6.13 (Mar 24) to 6.88, marking an increase of 0.75.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 3. It has increased from -0.02 (Mar 24) to 1.38, marking an increase of 1.40.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 3. It has increased from -0.58 (Mar 24) to 0.84, marking an increase of 1.42.
- For Enterprise Value (Cr.), as of Mar 25, the value is 56.21. It has increased from 25.30 (Mar 24) to 56.21, marking an increase of 30.91.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.35. This value exceeds the healthy maximum of 3. It has increased from 3.85 (Mar 24) to 7.35, marking an increase of 3.50.
- For EV / EBITDA (X), as of Mar 25, the value is 36.00. This value exceeds the healthy maximum of 15. It has increased from -847.15 (Mar 24) to 36.00, marking an increase of 883.15.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.19. This value exceeds the healthy maximum of 3. It has increased from 2.31 (Mar 24) to 6.19, marking an increase of 3.88.
- For Price / BV (X), as of Mar 25, the value is 3.11. This value exceeds the healthy maximum of 3. It has increased from 1.16 (Mar 24) to 3.11, marking an increase of 1.95.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.19. This value exceeds the healthy maximum of 3. It has increased from 2.31 (Mar 24) to 6.19, marking an increase of 3.88.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.11 (Mar 24) to 0.00, marking an increase of 0.11.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Norben Tea & Exports Ltd:
- Net Profit Margin: -2.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.27% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -1.16% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.84
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 64.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.61
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -2.3%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | 15-B Hemanta Basu Sarani, Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Manoj Kumar Daga | Chairman & Managing Director |
| Mr. Balkrishan Agarwal | Non Executive Director |
| Mr. Ashok Vardhan Bagree | Independent Director |
| Mr. Deepak Tiwari | Independent Director |
| Ms. Komal Bhotika | Independent Director |
| Ms. Tanusree Chatterjee | Independent Director |
| Mrs. Rashmi Sharma | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Norben Tea & Exports Ltd?
Norben Tea & Exports Ltd's intrinsic value (as of 29 January 2026) is ₹1.80 which is 97.94% lower the current market price of ₹87.50, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹136 Cr. market cap, FY2025-2026 high/low of ₹99.5/25.0, reserves of ₹4.46 Cr, and liabilities of ₹31.63 Cr.
What is the Market Cap of Norben Tea & Exports Ltd?
The Market Cap of Norben Tea & Exports Ltd is 136 Cr..
What is the current Stock Price of Norben Tea & Exports Ltd as on 29 January 2026?
The current stock price of Norben Tea & Exports Ltd as on 29 January 2026 is ₹87.5.
What is the High / Low of Norben Tea & Exports Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Norben Tea & Exports Ltd stocks is ₹99.5/25.0.
What is the Stock P/E of Norben Tea & Exports Ltd?
The Stock P/E of Norben Tea & Exports Ltd is .
What is the Book Value of Norben Tea & Exports Ltd?
The Book Value of Norben Tea & Exports Ltd is 12.9.
What is the Dividend Yield of Norben Tea & Exports Ltd?
The Dividend Yield of Norben Tea & Exports Ltd is 0.00 %.
What is the ROCE of Norben Tea & Exports Ltd?
The ROCE of Norben Tea & Exports Ltd is 3.90 %.
What is the ROE of Norben Tea & Exports Ltd?
The ROE of Norben Tea & Exports Ltd is 1.22 %.
What is the Face Value of Norben Tea & Exports Ltd?
The Face Value of Norben Tea & Exports Ltd is 10.0.